Jupiter Life Line Hospitals Ltd
Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]
- Market Cap ₹ 8,178 Cr.
- Current Price ₹ 1,247
- High / Low ₹ 1,625 / 1,152
- Stock P/E 42.3
- Book Value ₹ 221
- Dividend Yield 0.08 %
- ROCE 18.0 %
- ROE 15.0 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 43.6% CAGR over last 5 years
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE Healthcare BSE Allcap Nifty Microcap 250 Nifty Total Market
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 463 | 486 | 733 | 893 | 1,073 | 1,262 | 1,439 | |
| 379 | 419 | 580 | 691 | 831 | 965 | 1,106 | |
| Operating Profit | 84 | 67 | 153 | 201 | 242 | 297 | 332 |
| OPM % | 18% | 14% | 21% | 23% | 23% | 24% | 23% |
| 0 | 4 | 4 | 8 | 22 | 29 | 34 | |
| Interest | 26 | 39 | 44 | 42 | 26 | 11 | 29 |
| Depreciation | 26 | 31 | 36 | 39 | 42 | 57 | 82 |
| Profit before tax | 33 | 2 | 77 | 129 | 195 | 258 | 255 |
| Tax % | 10% | 248% | 34% | 43% | 10% | 25% | |
| 30 | -2 | 51 | 73 | 177 | 194 | 189 | |
| EPS in Rs | 5.83 | -0.45 | 10.05 | 12.90 | 26.94 | 29.51 | 28.77 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 4% | 3% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 20% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 44% |
| 3 Years: | 55% |
| TTM: | 1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -18% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 19% |
| Last Year: | 15% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 51 | 51 | 51 | 57 | 66 | 66 | 66 |
| Reserves | 186 | 188 | 243 | 309 | 1,103 | 1,291 | 1,385 |
| 272 | 426 | 495 | 469 | 0 | 393 | 403 | |
| 94 | 124 | 120 | 151 | 112 | 155 | 168 | |
| Total Liabilities | 603 | 789 | 909 | 986 | 1,281 | 1,905 | 2,023 |
| 435 | 630 | 684 | 720 | 718 | 977 | 998 | |
| CWIP | 10 | 26 | 27 | 29 | 74 | 185 | 296 |
| Investments | 2 | 7 | 3 | 2 | 17 | 114 | 526 |
| 156 | 126 | 195 | 235 | 473 | 628 | 203 | |
| Total Assets | 603 | 789 | 909 | 986 | 1,281 | 1,905 | 2,023 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 74 | 123 | 137 | 117 | 115 | 253 | |
| -43 | -295 | -84 | -104 | -246 | -209 | |
| -32 | 184 | 32 | 18 | 128 | 301 | |
| Net Cash Flow | -1 | 12 | 85 | 31 | -3 | 345 |
| Free Cash Flow | 46 | -118 | 46 | 40 | 29 | -67 |
| CFO/OP | 106% | 198% | 95% | 75% | 68% | 108% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 35 | 16 | 14 | 19 | 19 | 12 |
| Inventory Days | 64 | 48 | 39 | 44 | 41 | 38 |
| Days Payable | 268 | 217 | 157 | 164 | 120 | 163 |
| Cash Conversion Cycle | -169 | -152 | -104 | -101 | -59 | -113 |
| Working Capital Days | 17 | -7 | -24 | -24 | -5 | -20 |
| ROCE % | 7% | 17% | 21% | 22% | 18% |
Insights
In beta| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| ALOS (Average Length of Stay) Days |
|
||||
| ARPOB (Average Revenue Per Occupied Bed) INR |
|||||
| Average Occupancy Rate % |
|||||
| Operational Bed Capacity Number of Beds |
|||||
| Doctor Strength Numbers |
|||||
| Inpatient Volume Numbers |
|||||
| Outpatient (OPD) Volume Numbers |
|||||
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
27 Mar - MMRDA allotted ~10,026.44 sqm BKC land on 80-year lease; one-time premium ~Rs.354 Crore; for ~400-bed hospital.
- Closure of Trading Window 25 Mar
-
Announcement under Regulation 30 (LODR)-Credit Rating
10 Mar - ICRA assigned AA-(Stable) to Rs250 crore term loan; A1+ to Rs5 crore overdraft and Rs4 crore BG.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
27 Feb - Of Schedule of Analyst / Institutional Investor meetings under the SEBI (LODR) Regulations 2015.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
18 Feb - Of Schedule of Analyst / Institutional Investor meetings under the SEBI (LODR) Regulations 2015.
Concalls
-
Feb 2026Transcript PPT
-
Jan 2026TranscriptAI SummaryPPT
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Oct 2023TranscriptAI SummaryPPT
Hospital Portfolio[1][2]
The company operates 3 hospitals with 1,275 Doctors across:
a) Thane - 377 Operating Beds and 72.1% Average Occupancy
b) Pune - 309 Operating Beds and 54.9% Average Occupancy
c) Indore - 375 Operating Beds and 65.5% Average Occupancy